[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IT1393337B1 - Sintesi di (4as, 7as)-ottaidro-1h-pirrolo[3,4-b]piridina - Google Patents

Sintesi di (4as, 7as)-ottaidro-1h-pirrolo[3,4-b]piridina

Info

Publication number
IT1393337B1
IT1393337B1 ITMI2009A000332A ITMI20090332A IT1393337B1 IT 1393337 B1 IT1393337 B1 IT 1393337B1 IT MI2009A000332 A ITMI2009A000332 A IT MI2009A000332A IT MI20090332 A ITMI20090332 A IT MI20090332A IT 1393337 B1 IT1393337 B1 IT 1393337B1
Authority
IT
Italy
Prior art keywords
ottaidro
pirrolo
pyridine
Prior art date
Application number
ITMI2009A000332A
Other languages
English (en)
Inventor
Stefano Fogal
Andrea Castellin
Clark Ferrari
Giancarlo Arvotti
Riccardo Motterle
Elisabetta Motterle
Original Assignee
Italiana Sint Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italiana Sint Spa filed Critical Italiana Sint Spa
Priority to ITMI2009A000332A priority Critical patent/IT1393337B1/it
Priority to PCT/EP2010/052734 priority patent/WO2010100215A1/en
Priority to EP20100708517 priority patent/EP2403831B1/en
Priority to US13/056,458 priority patent/US8680276B2/en
Priority to CA2751548A priority patent/CA2751548C/en
Publication of ITMI20090332A1 publication Critical patent/ITMI20090332A1/it
Application granted granted Critical
Publication of IT1393337B1 publication Critical patent/IT1393337B1/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/16Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITMI2009A000332A 2009-03-06 2009-03-06 Sintesi di (4as, 7as)-ottaidro-1h-pirrolo[3,4-b]piridina IT1393337B1 (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ITMI2009A000332A IT1393337B1 (it) 2009-03-06 2009-03-06 Sintesi di (4as, 7as)-ottaidro-1h-pirrolo[3,4-b]piridina
PCT/EP2010/052734 WO2010100215A1 (en) 2009-03-06 2010-03-04 SYNTHESIS OF (4aS,7aS)-OCTAHYDRO-1H-PYRROLO[3,4-b]PYRIDINE
EP20100708517 EP2403831B1 (en) 2009-03-06 2010-03-04 SYNTHESIS OF (4aS,7aS)-OCTAHYDRO-1H-PYRROLOÝ3,4-b¨PYRIDINE
US13/056,458 US8680276B2 (en) 2009-03-06 2010-03-04 Synthesis of (4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridine
CA2751548A CA2751548C (en) 2009-03-06 2010-03-04 Synthesis of (4as,7as)-octahydro-1h-pyrrolo[3,4-b]pyridine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2009A000332A IT1393337B1 (it) 2009-03-06 2009-03-06 Sintesi di (4as, 7as)-ottaidro-1h-pirrolo[3,4-b]piridina

Publications (2)

Publication Number Publication Date
ITMI20090332A1 ITMI20090332A1 (it) 2010-09-07
IT1393337B1 true IT1393337B1 (it) 2012-04-20

Family

ID=41137093

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2009A000332A IT1393337B1 (it) 2009-03-06 2009-03-06 Sintesi di (4as, 7as)-ottaidro-1h-pirrolo[3,4-b]piridina

Country Status (5)

Country Link
US (1) US8680276B2 (it)
EP (1) EP2403831B1 (it)
CA (1) CA2751548C (it)
IT (1) IT1393337B1 (it)
WO (1) WO2010100215A1 (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITTO20110705A1 (it) 2011-07-29 2013-01-30 Italiana Sint Spa Procedimento di preparazione della moxifloxacina cloridrato e relativi intermedi
CN102952130B (zh) * 2011-08-24 2016-03-23 重庆华邦胜凯制药有限公司 手性合成(s,s)-2,8-二氮杂双环壬烷的方法
US9073881B2 (en) 2011-09-23 2015-07-07 Hoffmann-La Roche Inc. Benzoic acid derivatives
CN103497187A (zh) * 2013-09-25 2014-01-08 苏州维桢生物医药科技有限公司 一种用于工业上提高莫西沙星侧链化学纯度的方法
CN104016981B (zh) * 2014-06-23 2016-03-23 南京正大天晴制药有限公司 一种盐酸莫西沙星结构类似物及其制备方法
CN105566319B (zh) * 2014-10-09 2018-06-01 和鼎(南京)医药技术有限公司 一种(s,s)-2,8-二氮杂二环[4,3,0]壬烷的制备方法
CN104370907A (zh) * 2014-11-17 2015-02-25 安徽美诺华药物化学有限公司 喹诺酮衍生物的制备方法
CN110183445B (zh) * 2019-06-28 2021-08-24 昆明学院 莫西沙星及其衍生物的合成方法
CN112939849B (zh) * 2019-12-11 2022-05-03 浙江新和成股份有限公司 一种(s,s)-2,8-二氮杂双环[4.3.0]壬烷中间体及其制备方法和应用
CN111100125A (zh) * 2019-12-31 2020-05-05 厦门本素药业有限公司 莫西沙星中间体的制备方法
CN112759590B (zh) * 2020-11-19 2021-12-31 内蒙古源宏精细化工有限公司 一种莫西沙星的制备方法
CN112920184B (zh) * 2021-02-06 2022-03-01 台州市生物医化产业研究院有限公司 一种制备莫西沙星中间体(s,s)-2,8-二氮杂二环[4,3,0]壬烷的方法
CN112939847B (zh) * 2021-02-06 2022-05-13 台州市生物医化产业研究院有限公司 一种制备莫西沙星中间体(s,s)-2,8-二氮杂二环[4,3,0]壬烷的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3906365A1 (de) 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
TW209865B (it) * 1992-01-10 1993-07-21 Bayer Ag
DE4234078A1 (de) 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
DE19735198A1 (de) 1997-08-14 1999-02-18 Bayer Ag Verfahren zur Racematspaltung von cis- und trans-Pyrrolopiperidin
DE19751948A1 (de) 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
DE19821039A1 (de) 1998-05-11 1999-11-18 Bayer Ag Verfahren zur Herstellung von (S,S)-Benzyl-2,8-diazabicyclo[4.3.0]nonan
DE19927412A1 (de) 1999-06-16 2000-12-21 Bayer Ag Verfahren zur Enantiomerenanreicherung von cis-8-Benzyl-7,9-dioxo-2,8-diazabicyclo [4.3.0]nonan
DE19931115A1 (de) 1999-07-06 2001-01-11 Bayer Ag Racemisierung von R, S-Dioxo-Benzylpyrrolopiperidin
CA2434044A1 (en) 2001-01-11 2002-07-18 Bristol-Myers Squibb Pharma Company 1,2-disubstituted cyclic inhibitors of matrix metallorproteases and tnf-alpha
DE10226923A1 (de) 2002-06-17 2003-12-24 Bayer Ag Verfahren zur Enantiomerenanreicherung von cis-8-Benzyl-7,9-dioxo-2,8-diazabicyclo[4.3.0]nonan
WO2005012285A1 (en) 2003-08-05 2005-02-10 Matrix Laboratories Ltd An improved process for the preparation of moxifloxacin hydrochloride
WO2005054239A1 (en) 2003-12-05 2005-06-16 Bayer Healthcare Ag 2-aminopyrimidine derivatives
US20060111369A1 (en) 2004-11-10 2006-05-25 Somberg John C Synthesis, characterization and biological action of optically active isomers of floxacins
WO2006134491A2 (en) 2005-06-14 2006-12-21 Aurobindo Pharma Limited New crystalline form of moxifloxacin hydrochloride and process for its preparation
NL2000323C2 (nl) 2005-12-20 2007-11-20 Pfizer Ltd Pyrimidine-derivaten.
ES2284380B1 (es) 2006-03-10 2008-11-01 Quimica Sintetica S.A. Procedimiento para la preparacion de moxifloxacino y moxifloxacino clorhidrato.
CN101511190A (zh) 2006-07-11 2009-08-19 詹森药业有限公司 组胺h4受体的苯并呋喃并-和苯并噻吩并嘧啶调节剂
DE102006050516A1 (de) 2006-10-26 2008-04-30 Bayer Healthcare Ag Substituierte Dihydropyrazolone und ihre Verwendung
US7692655B2 (en) 2007-02-16 2010-04-06 Mitac International Corporation Apparatus and method of generating curved baseline for map labeling

Also Published As

Publication number Publication date
CA2751548A1 (en) 2010-09-10
EP2403831B1 (en) 2015-05-20
EP2403831A1 (en) 2012-01-11
ITMI20090332A1 (it) 2010-09-07
US8680276B2 (en) 2014-03-25
CA2751548C (en) 2017-04-11
WO2010100215A1 (en) 2010-09-10
US20110137036A1 (en) 2011-06-09

Similar Documents

Publication Publication Date Title
IT1393337B1 (it) Sintesi di (4as, 7as)-ottaidro-1h-pirrolo[3,4-b]piridina
IL235745A (en) Annotated 2-Aminopyridine
BRPI0914657A2 (pt) piridin-2-onae piridazin-3-onas substituídas
BRPI1006113A2 (pt) "derivado de piridina".
BR112012000763A2 (pt) derivados de piridin-4-ila
BRPI1013246A2 (pt) derivados de benzofuralina
DK2276486T3 (da) Nye substituerede imidazo-quinoliner
BRPI1013255A2 (pt) braços robóticos
ECSP12011999A (es) Derivados benzamida sustituidos
BRPI1014459A2 (pt) derivados de 3-(1,2,3-triazol-4-il)pirrolo[2,3-b]-piridina"
DK2397480T3 (da) Diazepindionderivat
BRPI1013844A2 (pt) derivados de piridina-isoxazol
BRPI1011683A2 (pt) derivado isoquinolina substituída
BRPI0908050A2 (pt) Furo-e tieno[3,2-c]piridinas
SMT201400013B (it) Attivatori di ampk tieno[2,3-B] piridina dione e loro impieghi terapeutici
ZA201206630B (en) Hetaryl-[1,8]naphthyridine derivatives
BR112012005400A2 (pt) derivados do tipo éter de heteroarilas bicíclicas
BRPI1014454A2 (pt) derivados de isoxazol-pirazol
BRPI1008754A2 (pt) sistema de alimentação central
BRPI1008173A2 (pt) "derivados de piridina espiroindolinona"
DK2387580T3 (da) Deoxyactagardinderivater
BR112012014058A2 (pt) derivados de 3,4,4a,10b- tetraidro-1h- tiopirano[4,3-c]isoquinolina
BRPI1011416A2 (pt) derivados de antraquinova novos
ZA201204429B (en) Ethynyl derivatives
BR112012002810A2 (pt) derivados de n1-acil-5-fluoropirimidinona